Kambiz Shekdar

This inventor holds 11 USPTO granted patents and 24 published patent applications and 11 EPO patents. Top assignees: Chromocell Corporation, Kraft Foods Group Brands LLC, Research Foundation to Cure Aids, Inc.. Active years: 2004-2023.

USPTO Granted Patents = 11 (Patent Applications = 24)

% Patents Active = 36.4

EPO Patents = 11 (Patent Applications = 20)

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

9 out of 13

Chromocell Corporation

patents

3 out of 286

Kraft Foods Group Brands LLC

patents

1 out of 1

Research Foundation to Cure Aids, Inc.

patent

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11680265 - Genome editing using effector oligonucleotides for therapeutic treatment (2023-06-20),

2. 10669547 - Genome editing using effector oligonucleotides for therapeutic treatment (2020-06-02),

3. 9872514 - Compounds, compositions, and methods for reducing or eliminating bitter taste (2018-01-23),

4. 9657357 - Methods and compositions for identifying and validating modulators of cell fate (2017-05-23),

5. 9534035 - Cell lines expressing ENaC and methods using them (2017-01-03),

6. 9408407 - Compounds, compositions, and methods for reducing or eliminating bitter taste (2016-08-09),

7. 9347934 - Assays for identifying compounds that modulate bitter taste (2016-05-24),

8. 8945848 - Methods and compositions for identifying and validating modulators of cell fate (2015-02-03),

9. 8916503 - Methods and materials using signaling probes (2014-12-23),

10. 8865779 - Compounds, compositions, and methods for reducing or eliminating bitter taste (2014-10-21),

11. 6692965 - Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences (2004-02-17),

Title: Innovator Spotlight: Kambiz Shekdar Revolutionizing Genome Editing for Therapeutic Treatment

Introduction

Kambiz Shekdar, a renowned inventor based in New York, NY, is making waves in the world of genome editing with his groundbreaking inventions. With a total of 11 patents to his name, Shekdar's work is paving the way for more effective and precise therapeutic treatments using effector oligonucleotides.

Latest Patents

His latest patents focus on "Genome editing using effector oligonucleotides for therapeutic treatment." These innovative compositions and methods involve effector oligonucleotides with greater than one mismatch compared to the target sequence. These advancements not only improve the efficiency of genomic editing but also offer potential therapeutic benefits for individuals in need.

Career Highlights

Throughout his career, Shekdar has made significant contributions to the field of biotechnology. He has worked with prestigious companies such as Chromocell Corporation and Kraft Foods Group Brands LLC, where his expertise and innovative spirit have been instrumental in driving forward exciting developments in the industry.

Collaborations

In his collaborative efforts, Shekdar has worked closely with esteemed colleagues such as Jessica Langer and Joseph Gunnet. Together, they have synergized their skills and expertise to push the boundaries of genome editing and bring about impactful changes in the realm of therapeutic treatments.

Conclusion

In conclusion, Kambiz Shekdar's dedication to innovation and advancement in genome editing is evident through his prolific patent portfolio and successful career milestones. His contributions are reshaping the landscape of biotechnology and holding promising prospects for future therapeutic interventions. Shekdar continues to inspire with his inventive spirit and unwavering commitment to driving positive change in the industry.